Insufficient early type I interferon responses can allow unchecked viral replication during the early onset of COVID-19, leading to an exaggerated release of pro-inflammatory cytokines, such as interleukin-6, interleukin-1β, and tumor necrosis factor alpha, resulting in the recruitment of neutrophils [24]. This evidence concerns the gene IL6 and COVID-19.